Literature DB >> 10460819

Treatment of diabetic retinopathy.

F L Ferris1, M D Davis, L M Aiello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10460819     DOI： 10.1056/NEJM199908263410907

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  39 in total

1.  Sugar creates a sticky business: round up the usual suspects.

Authors:  James T Rosenbaum
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 2.  Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research.

Authors:  R Donnelly; I Idris; J V Forrester
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

3.  Topographic change in the central macula coupled with contrast sensitivity loss in diabetic pregnancy.

Authors:  Sirpa Loukovaara; Mika Harju; Risto J Kaaja; Ilkka J R Immonen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-07-17       Impact factor: 3.117

4.  Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) Project: rationale and design.

Authors:  Steven Shea; Justin Starren; Ruth S Weinstock; Paul E Knudson; Jeanne Teresi; Douglas Holmes; Walter Palmas; Lesley Field; Robin Goland; Catherine Tuck; George Hripcsak; Linnea Capps; David Liss
Journal:  J Am Med Inform Assoc       Date:  2002 Jan-Feb       Impact factor: 4.497

5.  Diabetic Retinopathy and the NMDA Receptor.

Authors:  Sylvia B. Smith
Journal:  Drug News Perspect       Date:  2002-05

Review 6.  MANAGEMENT OF TYPE 2 DIABETES (NIDDM).

Authors:  M K Garg; K V Baliga
Journal:  Med J Armed Forces India       Date:  2011-07-21

7.  In vivo retinal and choroidal hypoxia imaging using a novel activatable hypoxia-selective near-infrared fluorescent probe.

Authors:  Shinichi Fukuda; Kensuke Okuda; Genichiro Kishino; Sujin Hoshi; Itsuki Kawano; Masahiro Fukuda; Toshiharu Yamashita; Simone Beheregaray; Masumi Nagano; Osamu Ohneda; Hideko Nagasawa; Tetsuro Oshika
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-29       Impact factor: 3.117

Review 8.  Diabetic complications and dysregulated innate immunity.

Authors:  Dana T Graves; Rayyan A Kayal
Journal:  Front Biosci       Date:  2008-01-01

Review 9.  Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.

Authors:  Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Curr Drug Targets       Date:  2013-07       Impact factor: 3.465

10.  Alternate serotype adenovector provides long-term therapeutic gene expression in the eye.

Authors:  Melissa M Hamilton; Gordon A Byrnes; Jason G Gall; Douglas E Brough; C Richter King; Lisa L Wei
Journal:  Mol Vis       Date:  2008-12-30       Impact factor: 2.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.